Vaccine Targeting Triple-Negative Breast Cancer Shows Good Response in First Clinical Trial of Patients
Favicon 
www.goodnewsnetwork.org

Vaccine Targeting Triple-Negative Breast Cancer Shows Good Response in First Clinical Trial of Patients

A drug that targets the deadliest form of breast cancer has recently been found to elicit no side effects‚ and triggered an immune response in 75% of patients. Conducted at the Cleveland Clinic with funding from the Pentagon‚ the vaccine was administered to 16 women in three separate doses. The form of the vaccine that […] The post Vaccine Targeting Triple-Negative Breast Cancer Shows Good Response in First Clinical Trial of Patients appeared first on Good News Network.